Impact of Pre-Treatment Lactate Dehydrogenase Levels on Prognosis and Bevacizumab Efficacy in Patients with Metastatic Colorectal Cancer

BACKGROUND: To investigate the impact of pre-treatment lactate dehydrogenase (LDH) levels on the outcome of patients with metastatic colorectal cancer treated with first-line chemotherapy with or without the anti-VEGF monoclonal antibody, bevacizumab, in a phase III prospective multicentre randomize...

Descripción completa

Detalles Bibliográficos
Autores principales: Passardi, Alessandro, Scarpi, Emanuela, Tamberi, Stefano, Cavanna, Luigi, Tassinari, Davide, Fontana, Annalisa, Pini, Sara, Bernardini, Ilaria, Accettura, Caterina, Ulivi, Paola, Frassineti, Giovanni Luca, Amadori, Dino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4526665/
https://www.ncbi.nlm.nih.gov/pubmed/26244985
http://dx.doi.org/10.1371/journal.pone.0134732

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4526665/
https://www.ncbi.nlm.nih.gov/pubmed/26244985
http://dx.doi.org/10.1371/journal.pone.0134732

Ejemplares similares